Cederbom S, Arkkukangas M Impact of the fall prevention Otago Exercise Programme on pain among community-dwelling older adults: a short- and long-term follow-up study. Clin Interv Aging. 2019 Apr 26;14:721-726. doi: 10.2147/CIA.S200188. eCollection 2019.
Giannakoulas G, Dimopoulos K Exercise training in congenital heart disease: should we follow the heart failure paradigm? Int J Cardiol. 2010 Jan 21;138(2):109-11. doi: 10.1016/j.ijcard.2009.06.024. Epub 2009 Jul 14.
Goodwin ML, Harris JE, Hernandez A, Gladden LB Blood lactate measurements and analysis during exercise: a guide for clinicians. J Diabetes Sci Technol. 2007 Jul;1(4):558-69. doi: 10.1177/193229680700100414.
Mat S, Ng CT, Tan PJ, Ramli N, Fadzli F, Rozalli FI, Mazlan M, Hill KD, Tan MP Effect of Modified Otago Exercises on Postural Balance, Fear of Falling, and Fall Risk in Older Fallers With Knee Osteoarthritis and Impaired Gait and Balance: A Secondary Analysis. PM R. 2018 Mar;10(3):254-262. doi: 10.1016/j.pmrj.2017.08.405. Epub 2017 Aug 18.
Nootens M, Wolfkiel CJ, Chomka EV, Rich S Understanding right and left ventricular systolic function and interactions at rest and with exercise in primary pulmonary hypertension. Am J Cardiol. 1995 Feb 15;75(5):374-7. doi: 10.1016/s0002-9149(99)80557-8.
Sun XG, Hansen JE, Oudiz RJ, Wasserman K Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation. 2001 Jul 24;104(4):429-35. doi: 10.1161/hc2901.093198.
Yang Y, Wang K, Liu H, Qu J, Wang Y, Chen P, Zhang T, Luo J The impact of Otago exercise programme on the prevention of falls in older adult: A systematic review. Front Public Health. 2022 Oct 20;10:953593. doi: 10.3389/fpubh.2022.953593. eCollection 2022.
Investigation of the Effects of the Otago Exercise Program in Adults With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.